ID   CSF2R_HUMAN             Reviewed;         400 AA.
AC   P15509; A7J003; A8KAM1; B4DW68; J3JS76; J3JS77; O00207; Q14429; Q14430;
AC   Q14431; Q16564;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   28-JUN-2023, entry version 218.
DE   RecName: Full=Granulocyte-macrophage colony-stimulating factor receptor subunit alpha;
DE            Short=GM-CSF-R-alpha;
DE            Short=GMCSFR-alpha;
DE            Short=GMR-alpha;
DE   AltName: Full=CDw116;
DE   AltName: CD_antigen=CD116;
DE   Flags: Precursor;
GN   Name=CSF2RA; Synonyms=CSF2R, CSF2RY;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=2555171; DOI=10.1002/j.1460-2075.1989.tb08541.x;
RA   Gearing D.P., King J.A., Gough N.M., Nicola N.A.;
RT   "Expression cloning of a receptor for human granulocyte-macrophage colony-
RT   stimulating factor.";
RL   EMBO J. 8:3667-3676(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=8144676; DOI=10.1016/s0021-9258(17)34144-3;
RA   Nakagawa Y., Kosugi H., Miyajima A., Arai K., Yokota T.;
RT   "Structure of the gene encoding the alpha subunit of the human granulocyte-
RT   macrophage colony stimulating factor receptor. Implications for the
RT   evolution of the cytokine receptor superfamily.";
RL   J. Biol. Chem. 269:10905-10912(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=1715577; DOI=10.1073/pnas.88.17.7744;
RA   Crosier K.E., Wong G.G., Mathey-Prevot B., Nathan D.G., Sieff C.A.;
RT   "A functional isoform of the human granulocyte/macrophage colony-
RT   stimulating factor receptor has an unusual cytoplasmic domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:7744-7748(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Placenta;
RX   PubMed=2148207; DOI=10.1093/nar/18.23.7178;
RA   Ashworth A., Kraft A.;
RT   "Cloning of a potentially soluble receptor for human GM-CSF.";
RL   Nucleic Acids Res. 18:7178-7178(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=1832774; DOI=10.1073/pnas.88.18.8203;
RA   Raines M.A., Liu L., Quan S.G., Joe V., DiPersio J.F., Golde D.W.;
RT   "Identification and molecular cloning of a soluble human granulocyte-
RT   macrophage colony-stimulating factor receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:8203-8207(1991).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4 AND 5).
RC   TISSUE=Blood;
RX   PubMed=8086503; DOI=10.1016/0167-4889(94)90241-0;
RA   Hu X., Emanuel P.D., Zuckerman K.S.;
RT   "Cloning and sequencing of the cDNAs encoding two alternative splicing-
RT   derived variants of the alpha subunit of the granulocyte-macrophage colony-
RT   stimulating factor receptor.";
RL   Biochim. Biophys. Acta 1223:306-308(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6).
RA   Hu X., Zuckerman K.S.;
RT   "Cloning and sequencing of the cDNA variant with 397 bp missing for the GM-
RT   CSF receptor alpha subunit.";
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7).
RX   PubMed=17681666; DOI=10.1016/j.exphem.2007.06.008;
RA   Pelley J.L., Nicholls C.D., Beattie T.L., Brown C.B.;
RT   "Discovery and characterization of a novel splice variant of the GM-CSF
RT   receptor alpha subunit.";
RL   Exp. Hematol. 35:1483-1494(2007).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 8).
RC   TISSUE=Synovium, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE OF 376-400.
RX   PubMed=1358805; DOI=10.1016/s0888-7543(05)80241-1;
RA   Rappold G., Willson T.A., Henke A., Gough N.M.;
RT   "Arrangement and localization of the human GM-CSF receptor alpha chain gene
RT   CSF2RA within the X-Y pseudoautosomal region.";
RL   Genomics 14:455-461(1992).
RN   [13]
RP   INVOLVEMENT IN SMDP4.
RX   PubMed=18955567; DOI=10.1084/jem.20080759;
RA   Martinez-Moczygemba M., Doan M.L., Elidemir O., Fan L.L., Cheung S.W.,
RA   Lei J.T., Moore J.P., Tavana G., Lewis L.R., Zhu Y., Muzny D.M.,
RA   Gibbs R.A., Huston D.P.;
RT   "Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene
RT   in the X chromosome pseudoautosomal region 1.";
RL   J. Exp. Med. 205:2711-2716(2008).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 218-320 IN COMPLEX WITH CSF2RB AND
RP   CSF2, SUBUNIT, AND GLYCOSYLATION AT ASN-229.
RX   PubMed=18692472; DOI=10.1016/j.cell.2008.05.053;
RA   Hansen G., Hercus T.R., McClure B.J., Stomski F.C., Dottore M., Powell J.,
RA   Ramshaw H., Woodcock J.M., Xu Y., Guthridge M., McKinstry W.J., Lopez A.F.,
RA   Parker M.W.;
RT   "The structure of the GM-CSF receptor complex reveals a distinct mode of
RT   cytokine receptor activation.";
RL   Cell 134:496-507(2008).
RN   [15]
RP   VARIANT SMDP4 ARG-196.
RX   PubMed=18955570; DOI=10.1084/jem.20080990;
RA   Suzuki T., Sakagami T., Rubin B.K., Nogee L.M., Wood R.E., Zimmerman S.L.,
RA   Smolarek T., Dishop M.K., Wert S.E., Whitsett J.A., Grabowski G.,
RA   Carey B.C., Stevens C., van der Loo J.C., Trapnell B.C.;
RT   "Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA.";
RL   J. Exp. Med. 205:2703-2710(2008).
CC   -!- FUNCTION: Low affinity receptor for granulocyte-macrophage colony-
CC       stimulating factor. Transduces a signal that results in the
CC       proliferation, differentiation, and functional activation of
CC       hematopoietic cells.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The beta subunit
CC       is common to the IL3, IL5 and GM-CSF receptors. The signaling GM-CSF
CC       receptor complex is a dodecamer of two head-to-head hexamers of two
CC       alpha, two beta, and two ligand subunits.
CC       {ECO:0000269|PubMed:18692472}.
CC   -!- INTERACTION:
CC       P15509; Q969F0: FATE1; NbExp=3; IntAct=EBI-1763264, EBI-743099;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 6]: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1;
CC         IsoId=P15509-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P15509-2; Sequence=VSP_001670;
CC       Name=3;
CC         IsoId=P15509-3; Sequence=VSP_001668, VSP_001669;
CC       Name=4;
CC         IsoId=P15509-4; Sequence=VSP_001665, VSP_001666;
CC       Name=5;
CC         IsoId=P15509-5; Sequence=VSP_001667;
CC       Name=6;
CC         IsoId=P15509-6; Sequence=VSP_001663, VSP_001664;
CC       Name=7; Synonyms=Alu-GMRalpha;
CC         IsoId=P15509-7; Sequence=VSP_043715;
CC       Name=8;
CC         IsoId=P15509-8; Sequence=VSP_044272;
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-surface
CC       receptor binding.
CC   -!- DOMAIN: The box 1 motif is required for JAK interaction and/or
CC       activation.
CC   -!- DISEASE: Pulmonary surfactant metabolism dysfunction 4 (SMDP4)
CC       [MIM:300770]: A rare lung disorder due to impaired surfactant
CC       homeostasis. It is characterized by alveolar filling with floccular
CC       material that stains positive using the periodic acid-Schiff method and
CC       is derived from surfactant phospholipids and protein components.
CC       Excessive lipoproteins accumulation in the alveoli results in severe
CC       respiratory distress. {ECO:0000269|PubMed:18955567,
CC       ECO:0000269|PubMed:18955570}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The gene coding for this protein is located in the
CC       pseudoautosomal region 1 (PAR1) of X and Y chromosomes.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 5
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA60962.1; Type=Miscellaneous discrepancy; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X17648; CAA35638.1; -; mRNA.
DR   EMBL; D26628; BAA05656.1; -; Genomic_DNA.
DR   EMBL; M64445; AAA35908.1; -; mRNA.
DR   EMBL; X54935; CAA38697.1; -; mRNA.
DR   EMBL; M73832; AAA35909.1; -; mRNA.
DR   EMBL; L29348; AAA60961.1; -; mRNA.
DR   EMBL; L29349; AAA60962.1; ALT_SEQ; mRNA.
DR   EMBL; U93096; AAB51535.1; -; mRNA.
DR   EMBL; DQ841258; ABI32309.1; -; mRNA.
DR   EMBL; AK293086; BAF85775.1; -; mRNA.
DR   EMBL; AK301395; BAG62930.1; -; mRNA.
DR   EMBL; BX649553; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002635; AAH02635.1; -; mRNA.
DR   EMBL; BC071835; AAH71835.1; -; mRNA.
DR   CCDS; CCDS35190.1; -. [P15509-5]
DR   CCDS; CCDS35191.1; -. [P15509-1]
DR   CCDS; CCDS35192.1; -. [P15509-3]
DR   CCDS; CCDS35193.1; -. [P15509-6]
DR   CCDS; CCDS55359.1; -. [P15509-7]
DR   CCDS; CCDS55360.1; -. [P15509-2]
DR   PIR; S06945; S06945.
DR   PIR; S13684; S13684.
DR   PIR; S50039; S50039.
DR   PIR; S50040; S50040.
DR   RefSeq; NP_001155001.1; NM_001161529.1. [P15509-1]
DR   RefSeq; NP_001155002.1; NM_001161530.1. [P15509-7]
DR   RefSeq; NP_001155003.1; NM_001161531.1. [P15509-2]
DR   RefSeq; NP_001155004.1; NM_001161532.1. [P15509-8]
DR   RefSeq; NP_006131.2; NM_006140.4. [P15509-1]
DR   RefSeq; NP_758448.1; NM_172245.2. [P15509-1]
DR   RefSeq; NP_758449.1; NM_172246.2. [P15509-5]
DR   RefSeq; NP_758450.1; NM_172247.2. [P15509-3]
DR   RefSeq; NP_758452.1; NM_172249.2. [P15509-6]
DR   RefSeq; XP_011543920.1; XM_011545618.2.
DR   RefSeq; XP_011543921.1; XM_011545619.1.
DR   RefSeq; XP_011543928.1; XM_011545626.1.
DR   RefSeq; XP_011543929.1; XM_011545627.2. [P15509-3]
DR   RefSeq; XP_011543930.1; XM_011545628.2. [P15509-3]
DR   RefSeq; XP_011544467.1; XM_011546165.2.
DR   RefSeq; XP_011544468.1; XM_011546166.1.
DR   RefSeq; XP_011544475.1; XM_011546173.1.
DR   RefSeq; XP_011544476.1; XM_011546174.2. [P15509-3]
DR   RefSeq; XP_011544477.1; XM_011546175.2. [P15509-3]
DR   RefSeq; XP_016884777.1; XM_017029288.1.
DR   RefSeq; XP_016885518.1; XM_017030029.1.
DR   PDB; 4NKQ; X-ray; 3.30 A; C=113-400.
DR   PDB; 4RS1; X-ray; 2.68 A; B=35-315.
DR   PDBsum; 4NKQ; -.
DR   PDBsum; 4RS1; -.
DR   AlphaFoldDB; P15509; -.
DR   SMR; P15509; -.
DR   BioGRID; 107825; 8.
DR   ComplexPortal; CPX-512; Granulocyte-macrophage colony-stimulating factor-receptor complex.
DR   CORUM; P15509; -.
DR   DIP; DIP-635N; -.
DR   IntAct; P15509; 5.
DR   STRING; 9606.ENSP00000394227; -.
DR   ChEMBL; CHEMBL2364169; -.
DR   DrugBank; DB11338; Clove oil.
DR   DrugBank; DB10770; Foreskin fibroblast (neonatal).
DR   DrugBank; DB10772; Foreskin keratinocyte (neonatal).
DR   DrugBank; DB05194; KB002.
DR   DrugBank; DB05386; Regramostim.
DR   DrugBank; DB00020; Sargramostim.
DR   DrugCentral; P15509; -.
DR   GuidetoPHARMACOLOGY; 1707; -.
DR   GlyCosmos; P15509; 11 sites, No reported glycans.
DR   GlyGen; P15509; 11 sites.
DR   iPTMnet; P15509; -.
DR   PhosphoSitePlus; P15509; -.
DR   BioMuta; CSF2RA; -.
DR   DMDM; 121509; -.
DR   jPOST; P15509; -.
DR   MassIVE; P15509; -.
DR   MaxQB; P15509; -.
DR   PeptideAtlas; P15509; -.
DR   ProteomicsDB; 5314; -.
DR   ProteomicsDB; 53157; -. [P15509-1]
DR   ProteomicsDB; 53158; -. [P15509-2]
DR   ProteomicsDB; 53159; -. [P15509-3]
DR   ProteomicsDB; 53160; -. [P15509-4]
DR   ProteomicsDB; 53161; -. [P15509-5]
DR   ProteomicsDB; 53162; -. [P15509-6]
DR   ProteomicsDB; 53163; -. [P15509-7]
DR   ABCD; P15509; 20 sequenced antibodies.
DR   Antibodypedia; 4251; 827 antibodies from 42 providers.
DR   CPTC; P15509; 1 antibody.
DR   DNASU; 1438; -.
DR   Ensembl; ENST00000355432.8; ENSP00000347606.3; ENSG00000198223.18. [P15509-5]
DR   Ensembl; ENST00000355805.7; ENSP00000348058.2; ENSG00000198223.18. [P15509-6]
DR   Ensembl; ENST00000381500.6; ENSP00000370911.1; ENSG00000198223.18. [P15509-3]
DR   Ensembl; ENST00000381509.8; ENSP00000370920.3; ENSG00000198223.18. [P15509-2]
DR   Ensembl; ENST00000381524.8; ENSP00000370935.3; ENSG00000198223.18. [P15509-1]
DR   Ensembl; ENST00000381529.9; ENSP00000370940.3; ENSG00000198223.18. [P15509-1]
DR   Ensembl; ENST00000432318.8; ENSP00000416437.2; ENSG00000198223.18. [P15509-1]
DR   Ensembl; ENST00000498153.7; ENSP00000512483.1; ENSG00000198223.18. [P15509-7]
DR   GeneID; 1438; -.
DR   KEGG; hsa:1438; -.
DR   MANE-Select; ENST00000381529.9; ENSP00000370940.3; NM_172245.4; NP_758448.1.
DR   UCSC; uc004cpn.3; human. [P15509-1]
DR   AGR; HGNC:2435; -.
DR   CTD; 1438; -.
DR   DisGeNET; 1438; -.
DR   GeneCards; CSF2RA; -.
DR   HGNC; HGNC:2435; CSF2RA.
DR   HPA; ENSG00000198223; Tissue enhanced (placenta).
DR   MalaCards; CSF2RA; -.
DR   MIM; 300770; phenotype.
DR   MIM; 306250; gene.
DR   MIM; 425000; gene.
DR   neXtProt; NX_P15509; -.
DR   OpenTargets; ENSG00000198223; -.
DR   Orphanet; 264675; Hereditary pulmonary alveolar proteinosis.
DR   PharmGKB; PA26938; -.
DR   VEuPathDB; HostDB:ENSG00000198223; -.
DR   eggNOG; ENOG502RZVR; Eukaryota.
DR   GeneTree; ENSGT00520000055993; -.
DR   HOGENOM; CLU_039627_2_0_1; -.
DR   InParanoid; P15509; -.
DR   OMA; DIQTEYV; -.
DR   OrthoDB; 5353959at2759; -.
DR   PhylomeDB; P15509; -.
DR   TreeFam; TF331549; -.
DR   PathwayCommons; P15509; -.
DR   Reactome; R-HSA-512988; Interleukin-3, Interleukin-5 and GM-CSF signaling.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-5683826; Surfactant metabolism.
DR   Reactome; R-HSA-5688849; Defective CSF2RB causes SMDP5.
DR   Reactome; R-HSA-5688890; Defective CSF2RA causes SMDP4.
DR   Reactome; R-HSA-912526; Interleukin receptor SHC signaling.
DR   SignaLink; P15509; -.
DR   SIGNOR; P15509; -.
DR   BioGRID-ORCS; 1438; 6 hits in 616 CRISPR screens.
DR   ChiTaRS; CSF2RA; human.
DR   EvolutionaryTrace; P15509; -.
DR   GenomeRNAi; 1438; -.
DR   Pharos; P15509; Tclin.
DR   PRO; PR:P15509; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P15509; protein.
DR   Bgee; ENSG00000198223; Expressed in monocyte and 121 other tissues.
DR   ExpressionAtlas; P15509; baseline and differential.
DR   Genevisible; P15509; HS.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0030526; C:granulocyte macrophage colony-stimulating factor receptor complex; IDA:ComplexPortal.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0019955; F:cytokine binding; IBA:GO_Central.
DR   GO; GO:0004896; F:cytokine receptor activity; IBA:GO_Central.
DR   GO; GO:0038023; F:signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0038157; P:granulocyte-macrophage colony-stimulating factor signaling pathway; IDA:ComplexPortal.
DR   GO; GO:0070665; P:positive regulation of leukocyte proliferation; IDA:ComplexPortal.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:ComplexPortal.
DR   GO; GO:0007259; P:receptor signaling pathway via JAK-STAT; IDA:ComplexPortal.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR040907; IL3Ra_N.
DR   InterPro; IPR003532; Short_hematopoietin_rcpt_2_CS.
DR   InterPro; IPR015321; TypeI_recpt_CBD.
DR   PANTHER; PTHR23037:SF35; -; 1.
DR   PANTHER; PTHR23037; CYTOKINE RECEPTOR; 1.
DR   Pfam; PF18611; IL3Ra_N; 1.
DR   Pfam; PF09240; IL6Ra-bind; 1.
DR   SUPFAM; SSF49265; Fibronectin type III; 2.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS01356; HEMATOPO_REC_S_F2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Disease variant;
KW   Disulfide bond; Glycoprotein; Membrane; Receptor; Reference proteome;
KW   Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..22
FT   CHAIN           23..400
FT                   /note="Granulocyte-macrophage colony-stimulating factor
FT                   receptor subunit alpha"
FT                   /id="PRO_0000010872"
FT   TOPO_DOM        23..320
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        321..346
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        347..400
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          220..320
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   MOTIF           306..310
FT                   /note="WSXWS motif"
FT   MOTIF           355..363
FT                   /note="Box 1 motif"
FT   CARBOHYD        46
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        54
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        99
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        123
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        135
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        182
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        195
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        223
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        229
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18692472"
FT   CARBOHYD        272
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        305
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        126..136
FT                   /evidence="ECO:0000250"
FT   DISULFID        165..178
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..133
FT                   /note="Missing (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044272"
FT   VAR_SEQ         216..233
FT                   /note="ERFNPPSNVTVRCNTTHC -> GSLGYSGCSRQFHRSKTN (in isoform
FT                   6)"
FT                   /evidence="ECO:0000303|Ref.7"
FT                   /id="VSP_001663"
FT   VAR_SEQ         234..400
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|Ref.7"
FT                   /id="VSP_001664"
FT   VAR_SEQ         271..286
FT                   /note="INVSGDLENRYNFPSS -> VVLTTGTSALCTFMCS (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:8086503"
FT                   /id="VSP_001665"
FT   VAR_SEQ         287..400
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:8086503"
FT                   /id="VSP_001666"
FT   VAR_SEQ         315
FT                   /note="F -> FGSHSVTQAGVQWHNLGSLQPPSPRLKRFSCLRLP (in isoform
FT                   7)"
FT                   /evidence="ECO:0000303|PubMed:17681666"
FT                   /id="VSP_043715"
FT   VAR_SEQ         316..400
FT                   /note="GSDDGNLGSVYIYVLLIVGTLVCGIVLGFLFKRFLRIQRLFPPVPQIKDKLN
FT                   DNHEVEDEIIWEEFTPEEGKGYREEVLTVKEIT -> DHLGGIHPRGRERLPRRGLDRE
FT                   GNYLRPRGCRNGMDISASATRGNCFLDDAVNLYIIFYVFI (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:8086503"
FT                   /id="VSP_001667"
FT   VAR_SEQ         318..333
FT                   /note="DDGNLGSVYIYVLLIV -> LGYSGCSRQFHRSKTN (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:1832774,
FT                   ECO:0000303|PubMed:2148207"
FT                   /id="VSP_001668"
FT   VAR_SEQ         334..400
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:1832774,
FT                   ECO:0000303|PubMed:2148207"
FT                   /id="VSP_001669"
FT   VAR_SEQ         376..400
FT                   /note="IIWEEFTPEEGKGYREEVLTVKEIT -> MGPQRHHRCGWNLYPTPGPSPGS
FT                   GSSPRLGSESSL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1715577"
FT                   /id="VSP_001670"
FT   VARIANT         196
FT                   /note="G -> R (in SMDP4; dbSNP:rs137852353)"
FT                   /evidence="ECO:0000269|PubMed:18955570"
FT                   /id="VAR_058507"
FT   STRAND          42..44
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          46..48
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          59..67
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          69..72
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          80..82
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          89..97
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          122..129
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   TURN            130..132
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          133..139
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          149..155
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          166..181
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          188..197
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          199..201
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          206..211
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   HELIX           212..215
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          222..227
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          233..238
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   HELIX           248..250
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          251..259
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          260..262
FT                   /evidence="ECO:0007829|PDB:4NKQ"
FT   STRAND          268..274
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          280..283
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   STRAND          292..300
FT                   /evidence="ECO:0007829|PDB:4RS1"
FT   TURN            301..303
FT                   /evidence="ECO:0007829|PDB:4RS1"
SQ   SEQUENCE   400 AA;  46207 MW;  D9025B981E41311D CRC64;
     MLLLVTSLLL CELPHPAFLL IPEKSDLRTV APASSLNVRF DSRTMNLSWD CQENTTFSKC
     FLTDKKNRVV EPRLSNNECS CTFREICLHE GVTFEVHVNT SQRGFQQKLL YPNSGREGTA
     AQNFSCFIYN ADLMNCTWAR GPTAPRDVQY FLYIRNSKRR REIRCPYYIQ DSGTHVGCHL
     DNLSGLTSRN YFLVNGTSRE IGIQFFDSLL DTKKIERFNP PSNVTVRCNT THCLVRWKQP
     RTYQKLSYLD FQYQLDVHRK NTQPGTENLL INVSGDLENR YNFPSSEPRA KHSVKIRAAD
     VRILNWSSWS EAIEFGSDDG NLGSVYIYVL LIVGTLVCGI VLGFLFKRFL RIQRLFPPVP
     QIKDKLNDNH EVEDEIIWEE FTPEEGKGYR EEVLTVKEIT
//
